Alan K. Matsumoto

Assistant Professor

1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alan K. Matsumoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
etoricoxib Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
nabumetone Medicine & Life Sciences
Placebos Medicine & Life Sciences
Oxymorphone Medicine & Life Sciences
Safety Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Osteoarthritis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis

Cohen, S., Pablos, J. L., Pavelka, K., Müller, G. A., Matsumoto, A. K., Kivitz, A., Wang, H. & Krishnan, E., Mar 29 2019, In : Arthritis Research and Therapy. 21, 1, 84.

Research output: Contribution to journalArticle

Rheumatoid Arthritis
Safety
Incidence
Biosimilar Pharmaceuticals
C-Reactive Protein

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study

Cohen, S., Genovese, M. C., Choy, E., Perez-Ruiz, F., Matsumoto, A. K., Pavelka, K., Pablos, J. L., Rizzo, W., Hrycaj, P., Zhang, N., Shergy, W. & Kaur, P., Oct 1 2017, In : Annals of the Rheumatic Diseases. 76, 10, p. 1679-1687 9 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Rheumatoid Arthritis
Safety
Odds Ratio
C-Reactive Protein

Pegloticase: A new biologic for treating advanced gout

Baraf, H. S. B. & Matsumoto, A. K., Apr 2012, In : International Journal of Clinical Rheumatology. 7, 2, p. 143-154 12 p.

Research output: Contribution to journalArticle

Gout
Hyperuricemia
Therapeutics
Urate Oxidase
Phase III Clinical Trials

Resolution of gouty tophi after twelve weeks of pegloticase treatment

Baraf, H. S. B., Matsumoto, A. K., Maroli, A. N. & Waltrip, R. W., Nov 2008, In : Arthritis and Rheumatism. 58, 11, p. 3632-3634 3 p.

Research output: Contribution to journalArticle

Urate Oxidase
Gout
Uric Acid
Pegloticase

Etoricoxib versus naproxen in patients with rheumatoid arthritis: A prospective, randomized, comparator-controlled 121-week trial

Matsumoto, A. K., Melian, A., Shah, A. & Curtis, S. P., Sep 2007, In : Current Medical Research and Opinion. 23, 9, p. 2259-2268 10 p.

Research output: Contribution to journalArticle

etoricoxib
Naproxen
Rheumatoid Arthritis
Placebos
Outcome Assessment (Health Care)